Kobayashi Akiko, Darragh Teresa, Herndier Brian, Anastos Kathryn, Minkoff Howard, Cohen Mardge, Young Mary, Levine Alexandra, Grant Linda Ahdieh, Hyun William, Weinberg Vivian, Greenblatt Ruth, Smith-McCune Karen
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California at San Francisco, San Francisco, California 94143-0128, USA.
Am J Pathol. 2002 Jan;160(1):151-64. doi: 10.1016/s0002-9440(10)64359-3.
The exact role of the mucosal immune response in the pathogenesis of human papillomavirus (HPV)-related premalignant and malignant diseases of the genital tract is poorly understood. We used immunohistochemical analysis to characterize immune cells in normal cervix (N = 21), HIV-negative high-grade dysplasia (N = 21), and HIV-positive high-grade dysplasia (N = 30). Classical germinal centers were present in 4.7% of normal cervix, 33% of high-grade lesions from HIV-negative women, and 3.3% of high-grade lesions from HIV-positive women (P = 0.003). HPV16 E7 antigen was detected in a subset of germinal centers, indicating that the secondary immune response was directed in part against HPV. Lymphoid follicles were present in 9.5% of normal cervix, 57% of HIV-negative high-grade dysplasia, and 50% of HIV-positive high-grade dysplasia (P = 0.001 normal versus high-grade). A novel type of lymphoid aggregate, consisting predominantly of CD8(+) T cells, was detected in 4.8% of normal cervix, 0% of HIV-negative high-grade dysplasia, and 40% of HIV-positive high-grade dysplasia (P < 0.001). The recurrence rate of high-grade dysplasia within one year was significantly higher in women with such CD8(+) T cell-dominant aggregates (P = 0.02). In summary, the types of lymphoid follicle in lesions from HIV-positive women were significantly different from those from HIV-negative women, and these differences are associated with the worse clinical outcome in HIV-positive women.
黏膜免疫反应在人乳头瘤病毒(HPV)相关的生殖道癌前病变和恶性疾病发病机制中的确切作用尚不清楚。我们采用免疫组织化学分析来表征正常宫颈(N = 21)、HIV阴性高级别发育异常(N = 21)和HIV阳性高级别发育异常(N = 30)中的免疫细胞。经典生发中心存在于4.7%的正常宫颈、33%的HIV阴性女性高级别病变以及3.3%的HIV阳性女性高级别病变中(P = 0.003)。在一部分生发中心检测到HPV16 E7抗原,表明二次免疫反应部分针对HPV。淋巴滤泡存在于9.5%的正常宫颈、57%的HIV阴性高级别发育异常以及50%的HIV阳性高级别发育异常中(正常与高级别相比,P = 0.001)。一种主要由CD8(+) T细胞组成的新型淋巴聚集物在4.8%的正常宫颈、0%的HIV阴性高级别发育异常以及40%的HIV阳性高级别发育异常中被检测到(P < 0.001)。具有这种CD8(+) T细胞主导聚集物的女性高级别发育异常在一年内的复发率显著更高(P = 0.02)。总之,HIV阳性女性病变中的淋巴滤泡类型与HIV阴性女性的显著不同,且这些差异与HIV阳性女性更差的临床结局相关。